Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Karyopharm Therapeutics shares are trading higher after the company announced the Phase 3 SEAL study met its primary endpoint.


Benzinga | Nov 3, 2020 01:12PM EST

Karyopharm Therapeutics shares are trading higher after the company announced the Phase 3 SEAL study met its primary endpoint.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC